Clinical Trial Update: Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study) [Phase 4]

View source ↗

Summary

Phase 4 OPERA trial update evaluating Ozurdex for diabetic macular edema in patients undergoing pars plana vitrectomy with membrane removal; trial completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Epiretinal Membrane

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Diabetic Macular Edema, Epiretinal Membrane | Phase 4 | Status: COMPLETED | Results posted: 2018-05-16